The Science Behind ACUVUE® OASYS® Brand Contact Lenses
Dear Colleagues,

We’re excited to share with you the latest research on lens performance and, specifically, a little of the history and science behind ACUVUE® OASYS® Brand Contact Lenses (senofilcon A).  For well over two decades, VISTAKON®, Division of Johnson & Johnson Vision Care, Inc. has been associated with excellence and leadership in contact lenses. Our goal has been to work closely with the professional community to meet your needs and exceed the expectations of your patients.

ACUVUE® OASYS® Brand is the most prescribed contact lens in the world today and one of the latest in the evolution of cutting edge technologies that VISTAKON® has brought to the market. The ACUVUE® OASYS® lens is a clear reflection of our dedication to innovation and to promoting the health of the millions of patients whose lives we together touch each year. Our patients are better for the wonderful partnership that exists between VISTAKON® and eyecare professionals throughout the world.

This supplement brings some of the brightest minds in the contact lens field together to discuss several pressing issues of the day. It is intended to serve as an open forum for honest feedback and ideas from practicing clinicians and educators. We share this with you and welcome your feedback by phone (800) 876-6644 or via e-mail at pa@its.jnj.com.

It is our sincere hope that the insights shared in this publication will provide knowledge and understanding to help manage the challenges of compliance, highlight optimal wearing schedule, and maximize contact lens performance and comfort. We are committed to working together to achieve the best possible outcomes for patients.

Colleen M. Riley, OD, MS, FAAO
Vice President of Professional Development & Medical Affairs